A Health Ministry panel has recommended compensation with a base amount of â‚¹20 lakh each for patients who received faulty hip implants from pharmaceutical giant Johnson & Johnson (J&J) seven years ago. The hip replacement device, sold in India by J&J's subsidiary DePuy International, was recalled in 2010, following global reports of metal poisoning and high failures.